RSNA 2011 

Abstract Archives of the RSNA, 2011


MSVM21

Breast/Nuclear Medicine/Molecular Imaging Series: Breast Imaging in the Era of Molecular Medicine

Multisession Courses — Breast (Imaging and Interventional), Molecular Imaging, Nuclear Medicine,

Presented on November 28, 2011

Participants

Robyn L. Birdwell MD, Presenter: Nothing to Disclose
Homer Aquino Macapinlac MD, Presenter: Speakers Bureau, Cardinal Health, Inc Medical Advisory Board, General Electric Company

Sub-Events

MSVM21-01     Genomic and Pathologic Features of Breast Cancer Subtypes
Andrea Richardson MD, PhD

MSVM21-02     Improving Localization of Malignant and Benign Breast Lesions with Structural Prior-guided Optical Imaging and Tomosynthesis
Daniel Kopans MD | Richard Moore | Qianqian Fang PhD | David Boas PhD

MSVM21-03     Radiogenomic Analysis of Breast Cancer Utilizing Gene Expression Profiling and Advanced MRI
Christopher Migdal | Ronald Korn MD, PhD | Michael Kuo MD | Shota Yamamoto MD | Daniel Maki MD

MSVM21-04     Predicting Prognosis Factors of Breast Cancer Using Optical Tomography with Ultrasonographic (US) Localization
Hak Hee Kim MD | Hee Jung Shin MD | Joo Hee Cha | Hyunji Kim MD | Joo Yeon Cheung MD | Jin Hee Moon MD

MSVM21-05     Clinical Feasibility Study of Combined Opto-Acoustic and Ultrasonic Imaging Modality Providing Coregistered Functional and Anatomical Maps of Breast Tumors
Alexander Oraevsky PhD | Pamela Otto MD | Kenneth Kist MD | N. Carol Dornbluth MD | Don Herzog MENG | Sergey Ermilov PhD | Vyacheslav Nadvoretsky PhD | Andre Conjusteau PhD | Richard Su PhD | Bryan Clingman MS | Ron Branstetter BS | Barbara McCorvey MD | Jason Zalev PhD

MSVM21-06     Nuclear Medicine Breast Imaging: Current Status and Future Directions
Wendie Berg MD, PhD

MSVM21-07     Low-Dose Molecular Breast Imaging with Tc-99m Sestamibi for Screening in Women with Mammographically Dense Breasts  
Michael O'Connor PhD | Carrie Hruska PhD | Cindy Tortorelli MD | Amy Conners MD | Deborah Rhodes MD | Robert Maxwell MD

MSVM21-08     Molecular Breast Imaging: A Comparison of Breast-specific Gamma Imaging (BSGI)—Mammography and Ultrasound in the Diagnostic Patient  
Jean Weigert MD | Margaret Bertrand MD | Leora Lanzkowsky MD | Lillian Stern MD

MSVM21-09     Imaging Findings of Bilateral Synchronous Breast Cancer: Mammography, Ultrasonography, MRI, and Breast-specific Gamma Imaging
Eun Suk Cha | Jee Eun Lee MD | Ji-Mi Huh | Sung Shine Shim | Seung Yon Baek MD

MSVM21-10     Quantitative FDG Uptake on High-Resolution Breast PET [Positron Emission Mammography (PEM)]: Correlation with Histopathologic Markers in Breast Cancer
Wendie Berg MD, PhD | Judith Kalinyak MD, PhD | Kathleen Madsen PhD | Kathy Turner

MSVM21-11     Evaluation of Response to Targeted Therapy Using Positron Emission Mammography (PEM)
Eric Rohren MD, PhD | Wei Wei | Wei Yang MD | Jenny Chang | Massimo Cristofanilli MD | Savitri Krishnamurthy MD | Naoto Ueno MD,PHD | Vicente Valero MD | Thomas Buchholz MD

MSVM21-12     Breast-specific Gamma Imaging for the Detection of Breast Cancer in Dense vs Nondense Breasts
Rachel Brem MD | Jocelyn Rapelyea MD | Jessica Torrente MD | Anita McSwain MD, MPH | Christine Teal | Caitrin Coffey BS | Jennifer Lieberman BA | Megan Kann BA

MSVM21-13     Current and Emerging Roles of Whole-Body PET Imaging in Breast Cancer
Richard Wahl MD

MSVM21-14     Prediction of Early Response to Neoadjuvant Chemotherapy in Advanced Breast Cancer Using Parallelly Installed PET/CT-MRI
Eun Sook Ko MD | Ilhan Lim MD | Joon Yeun Park | Ji Ae Park | Woo Chul Noh | Hyun-Ah Kim | Eun Kyu Kim | Seung Sook Lee | Kyeong Min Kim | Gi Jeong Cheon | Byung Il Kim | Chang Woon Choi | Sang Moo Lim

MSVM21-15     Low-Dose Molecular Breast Imaging (MBI): Initial Patient Results
Michael O'Connor PhD | Christina Tello-Skjerseth MD | Carrie Hruska PhD | Cindy Tortorelli MD | Robert Maxwell MD | Amy Conners MD | Eric Wagenaar

MSVM21-16     Multimodal Multiparametric PET-MRI in the Assessment of Breast Lesions
Thomas Helbich MD | Katja Pinker MD | Melanie Schernthaner MD | Hubert Bickel MD | Wolfgang Bogner MSC | Heinrich Magometschnigg

MSVM21-17     Correlation between DCE-MRI and 18F-FLT-PET in Patients with II-III Clinical Stage Breast Cancer before and after BEVACIZUMAB Administration
Amaja Garcia-Lallana | Luis Pina MD, PhD | Arlette Elizalde | Jose Manuel Lopez Vega | Valentina Boni | Jesus GarcÍa-Foncillas | Maria Garcia-Velloso MD, PhD

Cite This Abstract

Birdwell, R, Macapinlac, H, Breast/Nuclear Medicine/Molecular Imaging Series: Breast Imaging in the Era of Molecular Medicine.  Radiological Society of North America 2011 Scientific Assembly and Annual Meeting, November 26 - December 2, 2011 ,Chicago IL. http://archive.rsna.org/2011/11000798.html